Preliminary Evidence Of Anti Tumor Activity Of Selinexor (KPT-330) In a Phase I Trial Ofa First-In-Class Oral Selective Inhibitor Of Nuclear Export (SINE) In Patients (pts) With Relapsed / Refractory Non Hodgkin’s Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL)John Kuruvilla, Mansoor Raza Mirza, Boris Klebanov et al.|Blood|2013Cited by 30
Second primary malignancies in patients with lymphoma in Denmark after high-dose chemotherapy and autologous haematopoietic stem-cell transplantation: a population-based, retrospective cohort studyTrine Trab, Tarec Christoffer El‐Galaly, Judit Jørgensen et al.|The Lancet Haematology|2023Cited by 27
Cardiovascular diseases after high‐dose chemotherapy and autologous stem cell transplant for lymphoma: A Danish population‐based studyJoachim Bæch, Tarec Christoffer El‐Galaly, Simon Husby et al.|British Journal of Haematology|2023Cited by 6
P1225: SECONDARY PRIMARY MALIGNANCIES (SPM) AFTER HIGH-DOSE CHEMOTHERAPY (HDT) WITH AUTOLOGOUS STEM CELL TRANSPLANT (ASCT) FOR LYMPHOMA: A DANISH NATIONWIDE COHORT STUDYTrine Trab, Tarec Christoffer El‐Galaly, Joachim Bæch et al.|HemaSphere|2022Cited by 0
Clonal Hematopoiesis Mutations and Cell-Free DNA Characteristics in Patients with High-Risk Large B-Cell LymphomasMiro Nylén, Mikko Myllymäki, Leo Meriranta et al.|Blood|2024Cited by 0